AEON
AEON Biopharma·AMEX
--
--(--)
--
--(--)
AEON fundamentals
AEON Biopharma (AEON) released its earnings on Aug 12, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.6 (YoY -100.20%), missed estimates.
Revenue / YoY
0
--
EPS / YoY
-0.6
-100.20%
Report date
Aug 12, 2025
EPS
Actual | -228.24 | 303.84 | -11.52 | 3.75 | 2.28 | -0.6 |
Forecast | -22.32 | -13.68 | -11.52 | -12.96 | -13.68 | -0.35 |
Surprise | -922.58% | +2321.05% | 0.00% | +128.94% | +116.67% | -71.43% |
Revenue
Actual | 0 | 0 | 0 | 0 | 0 | 0 |
Forecast | 0 | 0 | 0 | 0 | 0 | 0 |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
What is the revenue and EPS growth rate for AEON Biopharma year over year?Did AEON Biopharma beat or miss consensus estimates last quarter?What does AEON Biopharma do and what are its main business segments?What is AEON Biopharma's gross profit margin?What guidance did AEON Biopharma's management provide for the next earnings period?What were the key takeaways from AEON Biopharma's earnings call?What factors drove the changes in AEON Biopharma's revenue and profit?What were the key takeaways from AEON Biopharma’s earnings call?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
